Gain of 1q Is Associated with Adverse Outcome in Favorable Histology Wilms’ Tumors
- 1 February 2001
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 158 (2) , 393-398
- https://doi.org/10.1016/s0002-9440(10)63982-x
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- High telomerase reverse transcriptase (hTERT) messenger RNA level correlates with tumor recurrence in patients with favorable histology Wilms' tumor.1999
- Allele loss in Wilms tumors of chromosome arms 11q, 16q, and 22q correlates with clinicopathological parametersGenes, Chromosomes and Cancer, 1998
- Comparative genomic hybridization analysis of Wilms tumorsCytogenetic and Genome Research, 1997
- Evidence for a familial Wilms' tumour gene (FWT1) on chromosome 17q12–q21Nature Genetics, 1996
- Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndromeNature Genetics, 1996
- THE GENETICS OF WILMS’ TUMOR—A Case of Disrupted DevelopmentAnnual Review of Genetics, 1994
- Germline and somatic abnormalities of chromosome 7 in Wilms' tumorCancer Genetics and Cytogenetics, 1994
- Cytogenetics and molecular genetics of Wilms' Tumor of childhoodCancer Genetics and Cytogenetics, 1992
- Response rates in relapsed wilms' tumor. A need for new effective agentsCancer, 1991
- Expression of Multidrug Resistance Gene in Human CancersJNCI Journal of the National Cancer Institute, 1989